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1. Introduction 
Amidrazones are class of compounds that have biological and pharmaceutical activity. They exhibit 
antibacterial and antifungal (Mamolo, et al.; 1992, Mamolo, 1993; and Ranft, et al.), antitumor 
(Modzelewska-Banachiewic, et al. 1999), or antitubercular (Abdel-Jalil, et al., 2010) activities. 
Amidrazones are also found to be effective herbicides (Dean et al., 2008). We have reported that 
amidrazones react with 1,4-benzoquinone or 1,4-naphthoquinone to give annulated 1,2,4-triazines (Aly et 
al., 2007), but with 2,3,5,6-tetrachloro-1,4-benzoquinone and 2,3-dichloro-1,4-naphthoquinone to afford 
indazole derivatives (Aly et al., 2007). We also reported that reaction of amidrazones with 1,4-dioxo-1,4-
dihydronaphthalene-2,3-dicarbonitrile gave a variety of 1,2,4-triazepines (Aly et al., 2008). On the other 
hand, reaction of amidrazones with 1,4-diphenyl-2-butyne-1,4-dione led to conjugate addition via the 
outermost nitrogen atom, without ring closure (Nour El-Din and Aly, 2007). Recently, we have reported 
N-Arylbenzamidrazones and ethyl 2-cyano-3-ethoxybut-2-enoate reacted together in ethanol and 
catalysed by triethylamine (Et3N) to give 5-amino-3-methyl-1-(aryl(phenylimino)methyl)-1H-
pyrazole derivatives. Reaction of the target amidrazones with bis-
(methylthio)methylidene)malononitrile in EtOH/Et3N/DMF mixture proceeded to give the 
corresponding 5-aminopyrazoles. The structure of the obtained products was proved by IR, mass, and 
NMR spectra and elemental analyses. Two-dimensional NMR spectroscopy and x-ray structural 
analyses were used to differentiate the assigned structures from other possible ring systems and 
regioisomers. The reaction mechanism is discussed. 
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that amidrazones reacted with phthaloyl chloride and diaminomaleonitrile (DAMN) to give triazolium 
chlorides (Aly et al., 2016) and N-4-amino-5-iminopyrazoles, respectively (Aly et al., 2016). Reaction of 
amidrazones with ethyl 2-cyano-3,3-bis(methylthio)acrylate led to conjugate addition, followed by ring 
closure with loss of methanethiol, to afford a series of mercapto pyrazoles (Aly et al., 2015). 
 Pyrazoles represent a key motif in heterocyclic chemistry and occupy a leading place in medicinal, 
pesticide and agrochemical industry (Liu et al., 2014) due to their potential to reveal a broad range of 
bioactivities such as anti-inflammatory (Kumar et al., 2009) antidepressant (Abdel-Aziz, et al., 2009), anti-
microbial (Manna K, Agrawal Y. K., 2009), antiviral (i.e. anti-influenza) (Shih, et al., 2010), anti-cancer 
(Balbi et al., 2011), anti-platelet (Rehse et al., 2009), anticonvulsant (Viveka et al., 2015), anti-biotic (Zhao 
et al., 2009) and CNS regulatory (O'Connor and Lysz, 2008). The pyrazole products are amidrazones 
themselves, of unusual stereochemistry. The central C2=N2 bond of the amidrazone moiety N1-N2=C2(Ar)-
N3Ar’, has been reported to have an E-configuration (Frohberg et al., 2012).23 There are few examples of 
amidrazones in the Z-configuration, especially when the structure contains heterocyclic instead of aryl 
substituents (Bhat et al., 2016 and Mazur et al., 2012). Therefore it becomes interesting to investigate the 
selectivity of amidrazones towards activated alkenes. Moreover, the appealing generality of this method is 
somewhat vitiated by the severe reaction conditions or the multistep sequences usually required to access 
the starting materials (Elguero et al., 1996). Therefore, both amidrazones and pyrazoles can be considered 
as potential drugs; in this paper, we report an efficient method for the synthesis of pyrazoles containing at 
N1 an aryliminobenzyl group.  
2. Results and Discussion 
Amidrazones 1a-f reacted with ethyl 2-cyano-3-ethoxybut-2-enoate (2) in absolute EtOH containing a 0.5 
ml of triethylamine (Et3N), compounds 3a-f (70-85%) were obtained, after chromatographic purification 
and recrystallization (Scheme 1).  
 
 Scheme 1. Synthesis of pyrazoles 3a-f 
Table 1. NMR assignment of compound 3b  
 
1H NMR (DMSO-d6) 
1H-1H COSY                   Assignment 
 
7.75 (bs; 2H) 
                
             NH2 
7.29 (m; 3H) 7.24                      H-p, m/o 
7.24 (m; 2H) 7.29                  H-o/m 
7.10 (d, J = 7.3; 2H) 6.91, 6.85, 2.19                H-6‘ 
6.91 (t, J = 7.3; 2H) 7.10, 6.85, 6.54, 2.19                 H-m’ 
6.85 (t, J = 7.3; 1H) 7.10, 6.91, 6.54                H-5’ 
6.54 (d, J = 7.6; 1H) 6.91, 6.85, 2.19               H-3’ 
4.24 (q, J = 7.1; 2H) 1.30               H-4b 
2.19 (s; 3H) 7.10, 6.91, 6.54                H-2a’ 
2.15 (s;3H)               H-3a 
1.30 (t, J = 7.1; 3H) 4.24             H-4c 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
13C NMR (DMSO-d6) 
 
HSQC 
 
HMBC 
 
Assignment 
 
163.80 
  
4.24, 2.15 
 
C-4a 
157.17  7.29, 7.24 C- 
153.81   C-5 
149.66  2.15 C-3 
145.63  7.10, 6.91, 6.85, 6.54 C-2’ 
131.21  7.29 C-i 
129.82 7.10 6.91, 2.19 C-6’ 
129.29 7.29 7.29, 7.24 C-p 
128.73b 7.24 7.29, 7.24 C-o/m 
128.48  6.85, 6.54, 2.19 C-1’ 
127.52b 7.29 7.29, 7.24 C-m/o 
125.86 6.91 7.10, 2.19 C-4’ 
123.60 6.85 6.54 C-5’ 
120.87 6.54 6.91, 6.85, 2.19 C-3’ 
92.40  2.15 C-4 
58.99 4.24 1.30 C-4b 
18.03 2.19 7.10, 6.54 C-2a’ 
18.30 2.04 6.91, 6.81 Ar-CH3 
14.41 2.15  C-3a 
14.36 1.30 4.24 C-4c          
 
15N NMR (DMSO-d6) 
 
 
 
HSQC 
 
 
HMBC 
 
 
Assignment 
277.4  2.15 N-2 
71.4 7.75  NH2 
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Elemental analyses and IR, NMR (1H, 13C, and 15N) and mass spectra were in good agreement with the 
assigned product structures. For example, compound 3b is the product of reaction between 2 and N-(o-
tolyl)benzamidrazone (1b). The o-tolyl ring gives four discrete 1H signals, two doublets and two “triplets” 
(double-doublets with equal J). Three of the four give weak COSY correlation with the tolyl methyl signal 
at H = 2.19; the “triplet” at H = 6.85 does not, and is assigned as the most distant proton, H-5’. The 
attached carbon at C = 123.60 gives HMBC correlation with a doublet at H = 6.54, assigned as H-3’; this 
would be a three-bond correlation. Similarly, correlations are observed between the other doublet at H = 
7.10, the other “triplet” at H = 6.91, and their attached carbons. In the phenyl ring, protons H-m/o and their 
attached carbons cannot be differentiated. In the pyrazole ring, a set of ethoxycarbonyl resonances is 
evident, and there is no nitrile carbon, indicating that N-1 attacks the nitrile carbon of 2 not the ester 
carbonyl. Methyl protons H-3a appear at H = 2.15, and the attached carbon appears at C = 14.41. Protons 
H-3a give HMBC correlation with a carbon at C = 92.40, assigned as C-4, and a nitrogen at N = 277.4, 
assigned as N-2; these are both three-bond correlations. The correlation between H-3a and N-2 proves the 
regioselectivity of the reaction. Nitrogens were detected indirectly, via HSQC or HMBC experiments; the 
nitrile nitrogen, N- and N-1 were  
not observed. Spectroscopic data appear in Table 1; the structure assignment of 3b is unambiguously 
confirmed by an X-ray crystal structure (Figure 1). Amidrazones 1a,d-g reacted with 
[bis(methylthio)methylidene]-malononitrile (4) in ethanol catalyzed by trimethylamine (0.5 ml) and 
containing enough DMF to dissolve the starting compounds, to furnish pyrazoles 5a,d-g in 65-76% yields 
(Scheme 2). Here again, we chose amidrazones bearing both electron-withdrawing and electron-donating 
substituents, to probe the effect of electron demand on the reaction. 
        
Figure 1. Molecular structure of 3b (displacement parameters are drawn at 50% probability level). 
 
Scheme 2. Reaction of amidrazones 1a,d-g with 2-(bismethylthio)methylene)malononitrile (4).  
Synthesis of E-5-amino-pyrazoles 5a,d-g 
For example, compound 5d is the product of reaction between 4 and N-(2,6-
dimethylphenyl)benzamidrazone (1d) (Table 2). The 2,6-dimethylphenyl ring provides a convenient 
starting point. The C-methyl protons and their attached carbon are distinctive at H = 2.04 and C = 18.30, 
respectively. The methyl carbon gives HMBC correlation with a 2H doublet at H = 6.91, assigned as H-m’; 
the attached carbons appear at C = 127.69. H-m’ gives COSY correlation with a 1H triplet at H = 6.81, 
assigned as H-p’; the attached carbon appears at C = 123.46. H-m’, H-p’, and ArCH3 all give HMBC 
correlation with a carbon at C = 144.24, assigned as H-i’: this is a three-bond coupling from CH3 and H-
m’, and a four-bond coupling from H-p’. H-p’ gives HMBC correlation with a carbon at C = 126.60, 
assigned as C-o’; this is a three-bond coupling. C-o’ gives no other HMBC correlation; this signal is the 
only intense carbon signal lacking attached protons. The protons of the mono-substituted phenyl ring barely 
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separate into a 1H triplet at H = 7.34, a 2H double-doublet at H = 7.26, and a 2H doublet at H = 7.22; 
these are assigned as H-p, H-m, and H-o respectively. The attached carbons appear at C = 130.08 (C-p), 
127.32 (C-m), and 128.49 (C-o). The protons of this ring gives HMBC correlation with a non-protonated 
carbon at C = 130.95, assigned as C-i. H-m, H-o, and C-CH3 also give HMBC correlation with one of the 
two carbon signals at C = 155.67-155.65, assigned as C-N-1 is observed, and gives HMBC correlation 
with the amino protons; this argues for structure 5d, in which it is a three-bond correlation, over its 
regioisomer 5d’ in which this correlation would cover four bonds (Figure 2).  
 Table 2. NMR assignment of compound 5d 
15N NMR (DMSO-d6) HSQC HMBC Assignment 
199.7  8.34 N-1 
71.8 8.34  NH2 
1H NMR (DMSO-d6) 
1H-1H COSY Assignment 
8.32 (bs; 2H)  NH2 
7.34 (t, J = 7.1; 1H) 7.26, 7.22 H-p 
7.26 (dd, J = 7.7, 7.4; 2H) 7.34, 7.22 H-m 
7.22 (d, J = 7.3; 2H) 7.34, 7.26 H-o 
6.91 (d, J = 7.5; 2H) 6.81 H-m‘ 
6.81 (t, J = 7.5; 1H) 6.91 H-p‘ 
2.28 (s; 3H)  SCH3 
2.04 (s; 6H)  ArCH3 
 
13C NMR (DMSO-d6) HSQC HMBC
 Assignment 
155.67, 155.65  7.26, 7.22, 6.81, 
2.04 
C-5 
149.58  2.28 C-3 
144.24  6.91, 6.81, 2.04 C-i’ 
130.95  7.34-7.22 C-i 
130.08 7.34 7.34-7.22 C-p 
128.49 7.22 7.34-7.22 C-o 
127.69 6.91 6.91, 6.81, 2.04 C-m’ 
127.32 7.26 7.34-7.22 C-m 
126.72  6.91, 6.81, 2.04 C-o’ 
123.46   C-p’ 
113.38   C-4a 
72.86  8.32 C-4 
18.30 2,04 6.91, 6.81 C-CH3 
12.81 2.28  SCH3 
 
  
Figure 2. Structure of 5d’ as an alternative structural isomer of compound 5d 
In the same series, but with the N-aryl ring bearing an electron-withdrawing group, is 5f (Table 3). This is 
the reaction product of 4 and N-(p-bromophenyl)benzamidrazone (1f). The p-bromophenyl ring gives two 
1H doublets at H = 7.34 and 6.75. The upfield of the two is assigned as H-o’, because it gives HMBC 
correlation with a nitrogen at N = 273.3, assigned as N-therefore, the signal at H = 7.34 is assigned as 
H-m’. The attached carbons appear at C = 123.95 (C-o’) and 131.28 (C-m’).  
Table 3. NMR assignment of compound 5f  
1H NMR (DMSO-d6) 1H-1H COSY Assignment 
8.34 (bs; 2H)  NH2 
7.34 (d, J = 8.5; 2H) 6.75 H-m‘ 
7.31 (m; 5H)  H-o,m,p 
6.75 (d, J = 8.6; 2H) 7.34 H-o‘ 
2.25 (s; 3H)  SCH3 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
The two non-protonated carbons in this ring, at C = 145.94 and 116.00, both give HMBC correlation with 
both H-o’ and H-m’; on chemical-shift grounds, they are assigned as C-i’ and C-p’ in that order. In the 
13C NMR (DMSO-d6) HSQC HMBC Assignment 
157.58  7.31 C- 
155.42   C-5 
149.93  2.25 C-3 
145.94  7.34, 6.75 C-i’ 
131.28 7.34 7.34 C-m’ 
130.31  7.31 C-i 
129.69 7.31 7.31 C-p 
129.44, 127.55 7.31 7.31 C-o,m 
123.95 6.75 6.75 C-o’ 
116.00  7.34, 6.75 C-p’ 
113.37   C-4a 
72.69  8.34 C-4 
12.78 2.25  SCH3 
    
15N NMR (DMSO-d6) 
 
273.3 
200.9 
72.2 
HSQC 
 
 
 
8.34 
HMBC 
 
6.75 
8.34 
Assignment 
 
N-

 
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phenyl ring, the protons appear as an unresolved envelope at H = 7.31; they give HSQC correlation with 
two intense 13C signals at C = 129.44 and 127.55, and a shorter line at C = 129.69. The last is assigned as 
C-p; the other two must be C-o/m, but cannot be differentiated. In the pyrazole ring, C-3 again gives 
HMBC correlation with the methyl protons, and N-1 with the amino protons. The structure assignment is 
confirmed by an X-ray crystal structure (Figure 3).  
 
Figure 3. Molecular structure of 5f (displacement parameters are drawn at 50% probability level)
 
Figure 4. Proposal intramolecular hydrogen bond formation in 5-aminopyrazoles 3a-f and 5a,d-g. 
The formation of E-configuration of the obtained 5-aminopyrazoles 3a-f and 5a,d-g might attributed to the 
proposed hydrogen bond forming between the hydrogen atoms of 5-substituted amino group of pyrazole 
moiety and the substituted nitrogen of the arylimino group as shown in Figure 4. We propose the 
mechanism shown in Scheme 3. Conjugate addition of 1 to 2 would give intermediate A. Elimination of 
methanethiol would provide B. Successive tautmoerism of B would then occur to give C and thereafter it 
would give D. Ultimately, aromatization of  D would give 5 (Scheme 3). 
 
 Scheme 3. Proposed mechanism for formation of pyrazoles 5 
3. Conclusion 
In this paper, we have unambiguously proved the E-form of the structure of 5-aminopyrazoles, in which the 
amino group is found in the same direction of substituted amino group (i.e. N-7 as in x-ray structure 
analyses, Figures 1 and 2). Most indicative of this paper is related to the good yields of the obtained 
products in addition to the simplicity of the method of preparation.  
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5. Experimental  
NMR spectra were measured on a Bruker AV-400 spectrometer (Bruker BioSpin Corp., Billerica, MA, 
USA) (400MHz for 1H and 100 MHz for 13C) at Florida Institute of Technology, USA. The 1H and 13C 
chemical shifts are given relative to internal standard TMS; 15N shifts are reported versus ammonia. For 
preparative thin layer chromatography (PLC), glass plates (20 x 48 cm) were covered with a slurry of silica 
gel Merck PF254 and air dried and developed using the solvents listed. Zones were detected by quenching 
of indicator fluorescence upon exposure to 254 nm UV light. Elemental analyses were carried in the 
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National Research center, Dokki, Cairo, Egypt. Mass spectrometry was performed by electron impact at 
70 eV, with a Finnigan MAT 8430 spectrometer in the National Research center, Dokki, Cairo, Egypt. IR 
spectra using KBr pellets, were run on a FT-IR (Bruker), Minia University, El-Minia, Egypt. Amidrazones 
1a-g were prepared according to reference (Doyle and Kurzer, 1974). Single crystal X-ray diffraction 
studies were carried out on Bruker D8 Venture diffractometer with Photon100 detector at 123 K using 
MoKα radiation (λ = 0.71073 Å). X-Ray structure analyses were carried out in laboratory of Inorganic 
Chemistry, Department of Chemistry, University of Helsinki, P.O. Box55 (A. I. Virtasenaukio I), 00014, 
Helsinki, Finland. 
General Procedures 
Reaction of amidrazones 1a-f with 2. General procedure (Scheme 1) 
A 100 mL round-bottom flask was flame-dried. Dry absolute ethyl alcohol (20 mL) containing a mixture of 
1a–f (1 mmol), 2 (1 mmol), and 0.5 mL of Et3N. The mixture was stirred under reflux for 6–10 h (the 
reaction was followed by TLC analysis). The solvent was then removed under vacuum and the residue was 
separated. The products 3a–f were obtained and were recrystallized from the stated solvents. 
Ethyl (E)-5-amino-1-((4’-methylphenylimino)(phenyl)methyl)3-methyl-1H-pyrazole-4-carboxylate 
(3a). Pale yellow crystals (CH2Cl2/MeOH), m.p. 171-172 
oC, yield 0.32 g (78%). IR (KBr, cm-1): 3410-
3285 (NH2), 3063 (CH aromatic), 2971 (CH aliphatic), 1675 (ester C=O), 1637, 1599 (C=N), 1549 (C=C). 
1H NMR (DMSO-d6; 2D): δH = 7.71 (bs, 2H; NH2), 7.30 (m, 3H; H-m,p\), 7.24 (m, 2H; H-o), 6.95(d, J = 
7.8, 2H; H-m’), 6.64 (d, J = 7.9, 2H; H-o’), 4.24, (q, J = 7.0, 2H; CH2), 2.17 (s, 3H; Tol-CH3), 2.14 (s, 3H; 
H-3a), 1.30 (t, J = 7.0, 3H; CH2CH3). 
13C NMR (DMSO-d6; 2D): δC = 163.8 (C=O), 157.6 (C-), 153.7 (C-
5), 149.6 (C-3), 144.2 (C-i‘), 132.4 (C-p‘), 131.2 (C-i), 129.2 (C-m,p), 129.0 (C-m‘), 127.6 (C-o), 121.5 (C-
o‘), 92.3 (C-4), 59.0 (CH2), 20.3 (Tol-CH3), 14.43 (C-3a), 14.35 (CH2CH3). 15N NMR (DMSO-d6; 2D): δN 
= 277.3 (N-2), 71.2 (NH2). MS: m/z (%): 429 (49, M+2), 427 (47, M
+), 225 (100), 179 (33), 76 (45). Calcd 
for C21H22N4O2 (362.43): C, 69.59; H, 6.12; N, 15.46. Found: C, 69.65; H, 6.00; N, 15.65.  
Ethyl (E)-5-amino-1-((2’-methylphenylimino)(phenyl)methyl)-3-methyl-1H-pyrazole-4-carboxylate 
(3b). Pale yellow crystals (CH2Cl2/MeOH), m.p. 139-140 
°C; yield 0.35 g (87%). IR (KBr, cm-1): 3454-
3329 (NH2), 3050 (CH aromatic), 2976 (CH aliphatic), 1682 (ester C=O), 1643, 1600 (C=N), 1576 (C=C).  
NMR: see Table 1. MS: m/z (%): 362 (M+, 20), 193 (100), 90 (20). Calcd for C21H22N4O2 (362.43): C, 
69.59; H, 6.12; N, 15.46. Found: C, 69.70; H, 6.24; N, 15.66.  
Ethyl (E)-5-amino-1-((2’,6’-dimethylphenylimino)(phenyl)-methyl)3-methyl-1H-pyrazole-4-
carboxylate (3c). Pale yellow crystals (CH2Cl2/ MeOH), m.p 172-173 
°C; yield 0.30 g (81%). IR (KBr, cm-
1): 3441-3318 (NH2), 3010 (CH aromatic), 2978 CH aliphatic), 1674 (ester C=O), 1642, 1601(C=N), 1543 
(C=C). 1H NMR (DMSO-d6; 2D): δH = 7.67 (bs, 2H; NH2), 7.33 (t, J = 7.2, 1H; H-p), 7.27 (dd, J = 7.6, 7.1, 
2H; H-m), 7.18 (d, J = 7.2, 2H; H-o), 6.91 (d, J = 7.5, 1H; H-p’), 4.25 (q, J = 7.1, 2H; CH2), 2.16 (s, 3H; H-
3a), 2.04 (s, 6H; Ar-CH3), 1.30 (t, J = 7.1, 3H; CH2CH3). 
13C NMR (DMSO-d6; 2D): δC = 163.8 (C=O), 
156.4 (C-), 153.9 (C-5), 149.6 (C-3), 144.5 (C-i‘), 131.5 (C-i), 129.8 (C-p), 128.2 (C-o), 127.7 (C-m‘), 
127.4 (C-m), 126.6 (C-o‘), 123.3 (C-p‘), 92.5 (C-4), 59.0 (CH2), 18.3 (Ar-CH3), 14.43 (C-3a), 14.39 
(CH2CH3). 
15N NMR (DMSO-d6; 2D): δN = 277.5 (N-2), 71.3 (NH2). MS: m/z (%): 376 (M+, 11), 207 
(100), 104 (15). Calcd for C22H24N4O2 (376.46): C, 70.19; H, 6.43; N, 14.88. Found: C, 70.00; H, 6.32; N, 
15.05. 
Ethyl (E)-5-amino-1-((4’-chlorophenylimino)(phenyl)-methyl)-3-methyl-1H-pyrazole-4-carboxylate 
(3d). White crystals (EtOH), m.p 166-167 oC; yield 0.33 g (77%). IR (KBr, cm-1): 3429-3298 (NH2), 3015 
(CH aromatic), 2967 (CH aliphatic), 1673 (ester C=O), 1637, 1592 (C=N), 1544(C=C). 1H NMR (DMSO-
d6; 2D): δH = 7.70 (bs, 2H; NH2), 7.32 (m, 3H; H-p,m/o), 7.26 (m, 2H; H-o/m), 7.20 (d, J = 8.4, 2H; H-m’), 
6.79 (d, J = 8.4, 2H; H-o’), 4.24 (q, J = 7.1, 2H; CH2), 2.14 (s, 3H; H-3a), 1.29 (t, J = 7.1, 3H; CH2CH3). 
13C NMR (DMSO-d6; 2D): δC = 163.8 (C=O), 158.2 (C-), 153.8 (C-5), 149.9 (C-3), 145.9 (C-i‘), 130.8 
(C-p‘), 129.4 (C-p), 129.2 (C-m/o), 128.4 (C-m‘), 127.65 (C-o/m), 127.60 (C-i), 123.5 (C-o‘), 92.3 (C-4), 
59.0 (CH2), 14.4 (C-3a), 14.3 (CH2CH3). 
15N NMR (DMSO-d6; 2D): δN = 277.0 (N-2), 272.2 (N-). MS: 
m/z (%): 384 (M+2, 9), 382 (M+, 27), 213 (100), 153 (16), 110 (14). Calcd for C20H19ClN4O2 (382.85): C, 
62.75; H, 5.00; N, 14.63. Found: 62.62; H, 5.15; N, 14.56. 
(E)-Ethyl 5-amino-1-((4’-bromophenylimino)(phenyl)methyl)3-methyl-1H-pyrazole-4-carboxylate 
(3e). Pale yellow crystals (MeOH), m.p. 150-151 oC; yield 0.32 g (76%). IR (KBr, cm-1): 3429-3297 (NH2), 
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3020 (CH aromatic), 2968 (CH aliphatic), 1673 (ester C=O), 1637, 1590 (C=N), 1543 (C=C). 1H NMR 
(DMSO-d6; 2D): δH = 7.70 (bs, 2H; NH2), 7.33 (m, 5H; H-p,m,m’), 7.28 (m, 2H; H-o), 6.74 (d, J = 8.5, 2H; 
H-o’), 4.24 (q, J = 7.1, 2H; CH2), 2.14 (s, 3H; H-3a), 1.30 (t, J = 7.1, 3H; CH2CH3). 13C NMR (DMSO-d6; 
2D): δC = 163.8 (C=O), 158.1 (C-), 153.8 (C-5), 149.9 (C-3), 146.3 (C-i‘), 131.3 (C-m), 130.8 (C-i), 129.4 
(C-p), 129.2 (C-o), 127.6 (C-m‘), 123.9 (C-o‘), 115.8 (C-p‘), 92.3 (C-4), 59.0 (CH2), 14.4 (C-3a), 14.3 
(CH2CH3). 
15N NMR (DMSO-d6; 2D): δN = 276.9 (N-2), 272.2 (N-). MS: m/z (%): 429 (M+2, 49), 427 
(M+, 47), 225 (100), 179 (33), 76 (45). Calcd for C20H19BrN4O2 (427.30): C, 56.22; H, 4.48; N, 13.11. 
Found: C, 56.06; H, 4.40; N, 13.06. 
Ethyl (E)-5-amino-1-((4’-nitrophenylimino)(phenyl)methyl)-3-methyl-1H-pyrazole-4-carboxylate 
(3f). Yellow crystals (CH2Cl2/cyclohexane), m.p. 183-184 
oC; yield 0.29 g (75%). IR (KBr, cm-1): 3444-
3329 (NH2), 3104 (CH aromatic), 2983 (CH aliphatic), 1688 (ester C=O), 1642, 1603 (C=N), 1547 (C=C). 
1H NMR (DMSO-d6; 2D): δH = 8.05 (d, J = 8.6, 2H; H-m’), 7.68 (bs, 2H; NH2), 7.32 (m, 5H; H-o.m.p), 
7.03 (d, J = 8.7, 2H; H-o’), 4.25 (q, J = 7.0, 2H; H-4b), 2.15 (s, 3H; H-3a), 1.30 It, J = 7.0, 3H; H-4c). 13C 
NMR (DMSO-d6; 2D): δC = 163.8 (C-4a), 158.0 (C-), 153.8, 153.6 (C-p’, 5), 150.4 (C-3), 143.1 (C-i’), 
130.6 (C-i), 129.7 (C-p), 129.2, 127.7 (C-o,m), 124.3 (C-m’), 122.6 (C-o’), 92.4 (C-4), 59.1 (C-4b), 14.5 
(C-3a), 14.3 (C-4c). 15N NMR (DMSO-d6; 2D): δN = 277.0 (N-2), 72.2 (NH2). MS: m/z (%):393 (M+, 25), 
224 (100), 178 (16), 88 (14). Calcd for C20H19N5O4 (393.40): C, 61.06; H, 4.87; N, 17.80. Found: C, 65.85; 
H, 4.80; N, 17.70.  
Reaction of amidrazones 1a,d-g with 4 (Scheme 2)  
General procedure  
A 100 mL round-bottom flask was flame-dried. Dry absolute ethyl alcohol (20 mL) containing a mixture of 
1a,d-g (1 mmol) and 4 (1 mmol) was added. The suspension solution was allowed to be dissolved by 
adding 0.5 mL of dimethylformamide (DMF). The mixture was stirred under reflux for 3–8 h (the reaction 
was followed by TLC analysis). The solvent was then removed under vacuum and the residue was 
separated. The products 5a,d–g were obtained and were recrystallized from the stated solvents. 
(E)-3-Amino-1-((phenylimino)(phenyl)methyl)-5-(methylthio)-1H-pyrazole-4-carbonitrile (5a). 
Yellow crystals (CH2Cl2/cyclohexane), m.p. 233-234 
°C; yield 0.25 g (75%). IR (KBr, cm-1): 3380-3260 
(NH2), 2215 (CN), 1650, 1560 (C=N), 1490 (C=C). 
1H-NMR (DMSO-d6; 2D): δH = 7.81 (bs, 2H; NH2), 
7.31 (m, 5H; H-o,m,p), 7.18 (dd, J = 7.8, 7.5, 2H; H-m’), 6.96 (t, J = 7.3, 1H; H-p’), 6.80 (d, J = 7.8, 2H; 
H-o’), 4.26 (q, J = 7.0, 2H; CH2), 2.09 (s, 3H; SCH3), 1.31 (t, J = 7.1, 3H; C-CH3). 13C NMR (DMSO-d6; 
2D): δC = 162.9 (C=O), 157.4 (C-), 154.0 (C-5), 149.8 (C-3), 146.8 (C-i‘), 130.7 (C-i), 129.5 (C-o), 129.4 
(C-p), 128.5 (C-m‘), 127.3 (C-m), 123.6 (C-p‘), 121.7 (C-o‘), 91.8 (C-4), 59.2 (CH2), 14.4 (C-CH3), 11.9 
(SCH3). 
15N NMR (DMSO-d6; 2D): δN = 72.3 (NH2). MS: m/z (%):  333 (M+, 20), 256 (100), 77 (21). 
Calcd. For C18H15N5S (333.41): C, 64.84; H, 4.53; N, 21.01. Found: C, 64.70; H, 4.50; N, 21.12.  
(E)-3-Amino-1-((2’,6’-dimethylphenylimino)(phenyl)methyl)-5-(methylthio)-1H-pyrazole-4-
carbonitrile (5d). Yellow crystals (EtOH), m.p. 244-245 °C; yield 0.28 g (77%). IR (KBr, cm-1): 3427-
3358(NH2), 3000 (CH aromatic), 2972 (CH aliphatic), 2213 (CN), 1649, 1612 (C=N), 1533 (C=C). NMR: 
Table 2. MS: m/z (%): 315 (20, M+), 214 (100). Calcd. For C20H19N5S (361.47): C, 66.46; H, 5.30; N, 
19.38. Found: C, 66.32; H, 5.22; N, 19.52.  
(E)-3-Amino-1-((4’-chlorophenylimino)(phenyl)methyl)-5-(methylthio)-1H-pyrazole-4-carbonitrile 
(5e). White crystals (CH3CN), m.p. 257-258 
°C; yield 0.27 g (73%). IR (KBr, cm-1): 3384-3258 (NH2), 
3015 (CH aromatic), 2928 (CH aliphatic), 2206 (CN), 1655, 1607 (C=N), 1540 (C=C). 1H-NMR (DMSO-
d6; 2D): δH = 7.78 (bs, 2H; NH2), 7.31 (m, 5H; H-p,m,o), 7.21 (d, J = 8.5, 2H; H-m’), 6.81 (d, J = 8.5, 2H; 
H-o’), 4.24 (q, J = 7.0, 2H; CH2), 2.07 (s, 3H; H-3a), 1.29 (t, J = 7.1, 3H; CH2CH3). 13C NMR (DMSO-d6; 
2D): δC = 162.9 (C=O), 158.0 (C-), 154.1 (C-5), 150.1 (C-3), 145.8 (C-i‘), 130.5 (C-p‘), 129.52, 129.50 
(C-i,p), 128.4 (C-m‘), 127.7, 127.4 (C-m,o), 123.5 (C-o‘), 91.8 (C-4), 59.3 (CH2), 14.4 (CH2CH3), 11.9 
(SCH3). 
15N NMR (DMSO-d6; 2D): δN = 270.5 (N-). MS: m/z (%): 369 (M+2, 7), 367 (M+, 21), 214 
(100), 111 (38), 77 (22). Calcd. For C18H14ClN5S (367.86): C, 58.77; H, 3.84; N, 19.04. Found: C, 58.62; 
H, 3.75; N, 18.88. 
(E)-3-Amino-1-((4’-bromophenylimino)(phenyl)methyl)-5-(methylthio)-1H-pyrazole-4-carbonitrile 
(5f). Yellow crystals (CH2Cl2/MeOH), m.p. 251-252 
°C; yield 0.31 g (76%). IR (KBr, cm-1): 3363-
3260(NH2), 3010 (CH aromatic), 2935 (CH aliphatic),2218 (CN), 1633, 1613 (C=N), 1547 (C=C). NMR: 
 14 
 
14 
Table 3. MS: m/z (%): 413 (M+2, 30), 411 (M+, 29), 306 (41), 259 (68), 153 (100), 136 (61), 106 (15). 
Calcd for C18H14BrN5S (412.31): C, 52.44; H, 3.42; N, 16.99. Found: C, 52.32; H, 3.35; N, 17.18.  
(E)-3-Amino-5-(methylthio)-1-((4’-nitrophenylimino)(phenyl)methyl)-1H-pyrazole-4-carbonitrile 
(5g). Yellow crystals (CH2Cl2/MeOH), m.p. 231-232 
°C; yield 0.27 g (71%). IR (KBr, cm-1): 3396-3265 
(NH2), 3015 (CH aromatic), 2982 (CH aliphatic), 2203 (CN), 1648, 1612 (C=N), 1587 (C=C). 
1H-NMR 
(DMSO-d6; 2D): δ 8.06 (d, J = 8.7, 2H; H-m’), 7.75 (b, 2H: NH2), 7.34 (m, 5H: H-o,m,p), 7.04 (d, J = 8.8, 
2H; H-o’), 4.24 (q, J = 7.0, 2H; CH2), 2.08 (s, 3H; SCH3), 1.29 (t, J = 7.0; C-CH3). 13C NMR (DMSO-d6; 
2D): δ 162.9 (C=O), 157.7 (C-), 154.1, 153.6 (C-5, i‘), 150.6 (C-p‘), 143.1 (C-p‘), 130.2, 129.9 (C-i, p), 
129.5, 127.5 (C-o, m), 124.4 (C-m‘), 122.7 (C-o‘), 91.8 (C-4), 59.3 (CH2), 14.4 (C-CH3), 12.0 (SCH3). 15N 
NMR (DMSO-d6; 2D): δ 73.1 (NH2). MS: m/z (%): 378 (M+, 15), 225 (100), 179 (33), 76 (45). Calcd. For 
C18H14N6O2S (378.41): C, 57.13; H, 3.73; N, 22.21. Found: 57.00; H, 3.65; N, 22.21.  
Single Crystal X-ray Structure Determinations of 3b and 5f: 
Single crystal X-ray diffraction studies were carried out on Bruker D8 Venture diffractometer with 
Photon100 detector at 123 K using MoKα radiation (λ = 0.71073 Å). Direct methods (3b) or Patterson 
Methods (5f) (Sheldrick, 2008) were used for the structure solution, and refinement was carried out using 
the method in Sheldrick, 2015 (full-matrix least-squares on F2). Hydrogen atoms were localized using a 
difference Fourier synthesis map and refined using a riding model [H (N) free]. Semi-empirical absorption 
correction were applied. For 3b an extinction correction was applied.  
Compound 3b: C21H22N4O2, Mr = 362.42 g mol
-1, colorless blocks, size 0.55 × 0.30 × 0.25 mm, 
monoclinic, P2/c (no.13), a = 11.3918(7) Å, b = 9.4638(6) Å, c = 18.3880(11) Å, β = 105.218(2)o, V = 
1912.9(2) Å3, Z = 4, Dcalcd = 1.258 Mg m
-3, F (000) = 768, μ = 0.083 mm-1, Τ = 123 K, 54567 measured 
reflections (2θmax = 55.2 o), 4405 independent [Rint = 0.031], 253 parameters, 2 restraints, R1 [for 3846 I › 
2σ (I)] = 0.036, wR2 (for all data) = 0.093, S = 1.04, largest diff. peak and hole = 0.326 eÅ-3 / - 0.180 e Ǻ-3. 
Compound 5f: C18H14BrN5S, Mr = 412.31 g mol
-1, yellow plates, size 0.30 × 0.05 × 0.05 mm, triclinic, P-1 
(no.2), a = 6.1213(3) Å, b = 7.9546(4) Å, c = 18.2014(8) Å, α = 86.045(2)°, β = 85.577(2)o, γ = 88.466(2)o, 
V = 881.32(7) Å3, Z = 2, Dcalcd = 1.554 Mg m
-3, F (000) = 416, μ = 2.461 mm-1, Τ = 123 K, 18037 
measured reflections (2θmax = 55°), 4037 independent [Rint = 0.034], 233 parameters, 2 restraints, R1 [for 
3622 I › 2σ (I)] = 0.027, wR2 (for all data) = 0.057, S = 1.08, largest diff. peak and hole = 0.356 e Ǻ-3/ - 
0.350 e Å-3. 
CCDC 1476346 (3b), and 1476347 (5f) contain the supplementary crystallographic data for this paper. 
These data can be obtained free of charge from The Cambridge Crystallographic Data Centre via 
www.ccdc.cam.ac.uk/data_request/cif.  
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